AnaptysBio (ANAB) Stock Price & Analysis

ANAB$46.25-1.52 -3.18%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$1.38BEnterprise value$1.25BRevenue (TTM)$191.57MMarket position—

Score

78
Bullish
Value
62
Quality
72
Growth
100

AI Analysis

Snapshot

AnaptysBio mixes growth with a still-reasonable multiple — Growth 100/100 with P/E 7.3. Under the hood: P/E 7.3, plus revenue compounding ~219% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

62
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

72
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

AnaptysBio, Inc. (ANAB) last printed $46.25. Equity value is $1.38B. Trailing earnings multiple 7.48. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$16.68M$10M$5M$8M$75M$63.17M$10.29M$17.16M$91.28M$234.6M

About

Company description is not on file.

AnaptysBio (ANAB) Stock Price & Analysis

ANAB price $46.25 -1.52 -3.18%

Ticker
ANAB
Price
$46.25
Change
-1.52 -3.18%
Market cap
$1.38B
P/E
7.48
Forward P/E
5.34
Dividend yield
0.00%
Beta
0.49
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
78
Value
62
Quality
72
Growth
100

Stocklytics score rationale: value 62, quality 72, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener